A study of monozygotic twins allowed researchers to discover which parts of immune dysfunction in multiple sclerosis were influenced by genetics, and which were influenced by environmental factors.
Using titanate nanowires treated with cerebrolysin, researchers have been able to target delivery to the brain and through the central nervous system. Researchers report the use of nanowires to deliver drugs could be beneficial in the treatment of Alzheimer's, Parkinson's and other neurodegenerative diseases.
A new study sheds light on the role oligodendrocytes play in the development and progression of multiple sclerosis.
Researchers have developed small molecules that inhibit one of the main enzymes implicated in autoimmune response. The research could lead to potential new medications for a range of autoimmune diseases.
A new study reports a three fold risk for people who carry variants of two specific genes in developing multiple sclerosis.
Researchers propose a new model for Alzheimer's disease (AD2) that considers the neurodegenerative disease as an autoimmune disease that attacks the brain. Considering Alzheimer's as an autoimmune disorder could spark a new line of therapies to treat the disease.
By fusing a cytokine to a blood protein, researchers have developed a new therapy to help treat multiple sclerosis.
A newly discovered subset of dendritic cells have been implicated in sexually transmitted HIV infection. The CD11c+ dendritic cells are found in human genital tissue at the epithelial level. They are the first immune cells to interact with the HIV virus. The cells directly transfer the virus to CD4 T cells, making them key drivers in HIV transmission.
Studying animal models, researchers have identified previously unknown types of immune cells that are present in the brains of those with multiple sclerosis.